Recovery Act Web Site Highlights NCI Clinical Proteomic Technologies for Cancer Initiative
NCI's American Recovery and Reinvestment Act (ARRA) Web site features new content that highlights the NCI Clinical Proteomic Technologies for Cancer (CPTC) program and describes how Recovery Act funding is helping support an initiative to measure the 250,000 to 1,000,000 proteins in the human body. This pilot project is studying the feasibility and scalability of emerging technologies to accurately measure such large numbers of proteins. By studying the human proteome, researchers hope to learn more about how cancer originates and devise new and better methods for diagnosis, treatment, and prevention.
Learn more about CPTC and other important initiatives here.